Difference between revisions of "Al Shahrani M"
From Bioblast
Nirschl Lisa (talk | contribs) |
Nirschl Lisa (talk | contribs) |
||
| Line 13: | Line 13: | ||
{{Labelingperson}} | {{Labelingperson}} | ||
== Participated at == | == Participated at == | ||
::::*[[IOC101| IOC101 London UK]] | |||
::::* [[IOC100| IOC100 Schroecken AT]] | ::::* [[IOC100| IOC100 Schroecken AT]] | ||
Latest revision as of 10:49, 26 April 2018
| Name | Al Shahrani Mesfer, |
|---|---|
| Institution | The National Hospital for Neurology & Neurosurgery
Neurometabolic Unit |
| Address | Queen Square, WC1N 3BG |
| City | London |
| State/Province | |
| Country | United Kingdom |
| [email protected] | |
| Weblink | |
| O2k-Network Lab | UK London Land JM |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Hargreaves 2016 Drug Saf | 2016 | Hargreaves IP, Al Shahrani M, Wainwright L, Heales SJR (2016) Drug-induced mitochondrial toxicity. Drug Saf 39:661–74. https://doi.org/10.1007/s40264-016-0417-x. |
